ExodusPoint Capital Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Buy |
+176,276
| New | +$1.27M | 0.01% | 837 |
|
|
2025
Q1 | – | Sell |
-67,381
| Closed | -$526K | – | 1454 |
|
|
2024
Q4 | $526K | Buy |
67,381
+23,404
| +53% | +$183K | ﹤0.01% | 1042 |
|
|
2024
Q3 | $475K | Buy |
+43,977
| New | +$475K | ﹤0.01% | 1127 |
|
|
2024
Q1 | – | Sell |
-179,415
| Closed | -$1.06M | – | 1423 |
|
|
2023
Q4 | $1.06M | Buy |
179,415
+158,080
| +741% | +$930K | 0.01% | 738 |
|
|
2023
Q3 | $208K | Sell |
21,335
-15,505
| -42% | -$151K | ﹤0.01% | 1469 |
|
|
2023
Q2 | $436K | Buy |
+36,840
| New | +$436K | ﹤0.01% | 1319 |
|
|
2023
Q1 | – | Sell |
-403,625
| Closed | -$4.67M | – | 1703 |
|
|
2022
Q4 | $4.67M | Buy |
+403,625
| New | +$4.67M | 0.07% | 356 |
|
|
2021
Q2 | – | Sell |
-217,630
| Closed | -$1.91M | – | 2333 |
|
|
2021
Q1 | $1.91M | Buy |
217,630
+82,780
| +61% | +$727K | 0.03% | 554 |
|
|
2020
Q4 | $1.51M | Buy |
+134,850
| New | +$1.51M | 0.01% | 615 |
|